Open tender · Notice 094438-2026
WBS-FTS-64245 Haematology Testing System
- Value
- £409k
- Closes
- 4 Nov 2026 (20 days)
- Where
- Wales
- Lots
- 1
- Suitable for SMEs
- Not stated
- Contract
- 1 Apr 2027 – 31 Mar 2032
In plain English
Velindre University NHS Trust (Welsh Blood Service) wants to buy an advanced automated haematology analysis system for blood donor assessment, blood component quality monitoring and research, in Wales, for a contract running from 1 April 2027 to 31 March 2032.
Good fit for: Medical device suppliers of haematology analysers with experience in blood service or blood establishment settings
- Must show experience in blood services or comparable blood establishments
provide evidence of successful implementation within blood services, blood centres or comparable blood establishments
- Needs a mature quality management system and regulatory compliance
demonstrate compliance with applicable medical device regulations, support quality and regulatory requirements through a mature quality management system
- Must have robust External Quality Assessment (EQA/EQAS) programme participation
supported by robust External Quality Assessment (EQA/EQAS) programmes and can demonstrate meaningful peer group benchmarking
Written with AI from the official notice. Check the notice before relying on it.
What the buyer says
The Welsh Blood Service (WBS) requires an advanced automated haematology analysis system to support blood donor assessment, blood component quality monitoring, research and innovation activities. The proposed solution will be required to provide automated full blood count (FBC) analysis, 5-part white cell differential capability and integrated reticulocyte analysis on the primary analyser. Of particular interest are systems capable of generating the data required to support emerging donor health assessment methodologies, including FlowScore calculation and reticulated haemoglobin analysis for the early detection of iron deficiency in blood donors. The requirement is includes advanced analytical capabilities that support the unique operational needs of a blood establishment. These include fluorescence platelet counting with high accuracy at low platelet concentrations, reticulated platelet measurement, low-level white cell enumeration suitable for blood component quality monitoring, and the ability to perform blood component testing without the need for separate instrumentation. Suppliers should be able to demonstrate how their platforms support routine blood component quality control programmes through dedicated blood bank functionality and provide evidence of successful implementation within blood services, blood centres or comparable blood establishments. WBS is particularly interested in solutions that are supported by robust External Quality Assessment (EQA/EQAS) programmes and can demonstrate meaningful peer group benchmarking through sufficient participant numbers using the same analyser platform and methodology. Suppliers should be able to demonstrate compliance with applicable medical device regulations, support quality and regulatory requirements through a matu…
Procedure: Open procedure (Open: anyone can bid, in one stage). Published 6 Oct 2026.
Want tenders like this, matched to your firm?
Winnable emails the few new tenders that fit you each weekday, with the catch spelled out. £29/month after a 14-day free trial (card needed to start, nothing charged during it).